GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (FRA:A2T) » Definitions » Revenue

Atrys Health (FRA:A2T) Revenue : €206.7 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Atrys Health Revenue?

Atrys Health's revenue for the six months ended in Jun. 2024 was €107.4 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €206.7 Mil. Atrys Health's Revenue per Share for the six months ended in Jun. 2024 was €1.42. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €2.67.

Warning Sign:

Atrys Health SA revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Atrys Health was 19.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 37.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 50.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, Atrys Health's highest 3-Year average Revenue per Share Growth Rate was 82.00% per year. The lowest was 15.60% per year. And the median was 37.00% per year.


Atrys Health Revenue Historical Data

The historical data trend for Atrys Health's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Revenue Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 14.84 31.40 121.01 158.37 201.57

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.91 69.46 102.28 99.29 107.44

Competitive Comparison of Atrys Health's Revenue

For the Biotechnology subindustry, Atrys Health's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Revenue distribution charts can be found below:

* The bar in red indicates where Atrys Health's Revenue falls into.



Atrys Health Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €206.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health  (FRA:A2T) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Atrys Health Revenue Related Terms

Thank you for viewing the detailed overview of Atrys Health's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health Business Description

Traded in Other Exchanges
Address
Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health Headlines

No Headlines